Compare Bank of Nova Scotia (BNS) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Nova Scotia vs Teladoc Health Inc — how do they compare? Bank of Nova Scotia trades at $89.03 (market cap $108.32B), while Teladoc Health Inc trades at $6.67 (market cap $1.24B). The key difference: Bank of Nova Scotia is far larger — about 87.4× Teladoc Health Inc's market cap, and Bank of Nova Scotia pays a 3.64% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| BNS | TDOC | |
|---|---|---|
Market Cap | $108.32B | $1.24B |
Sector | Financials | Health |
52-Week High | $90.29 | $9.72 |
52-Week Low | $56.41 | $4.47 |
Dividend Yield | 3.64% | — |
Enterprise Value | — | $1.50B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bank of Nova Scotia (BNS) trades at $90.34, up 2.01% with a bullish technical outlook supported by moving averages. The bank has delivered three consecutive earnings beats, with Q2 2026 EPS expected at $1.53. Recent acquisition of MapleMark Bank and dividend increase to $1.14 demonstrate strategic growth initiatives. Valuation metrics show P/E of 17.1 and P/B of 1.96, while maintaining strong profitability with 24.86% net income margin.
BNS presents a compelling investment case with strong fundamentals and analyst support (52.63% buy ratings), though revenue growth has been modest and interest expenses remain elevated. The stock faces risks from economic uncertainty and credit quality concerns, but dividend stability and improving ROE to 11.87% provide downside protection. Upside potential exists if the bank maintains earnings momentum.
Teladoc Health (TDOC) trades at $6.62, down 6.5% on the day, reflecting investor concern after a Q2 2026 revenue miss and lowered full-year guidance. The stock is technically bearish with key support at $6, while fundamentals show revenue of $2.53B in 2025 but persistent net losses, with a negative net income margin of -7.13%. Recent news highlights multiple law firm investigations into the company following its guidance cut.
The outlook remains challenging due to weak BetterHelp performance and ongoing losses, though valuation ratios like P/S of 0.49 and EV/EBITDA of 6.96 suggest potential undervaluation. Risks include competitive pressures and legal scrutiny, but analyst consensus price target of $8.88 implies upside if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Nova Scotia
Bank of Nova Scotia is a global financial services provider. The bank has five business segments: Canadian banking, international banking, global wealth management, global banking and markets, and other. It offers a range of advice, products, and services, including personal and commercial banking, wealth management and private banking, corporate and investment banking, and capital markets. The bank's international operations span numerous countries and are more concentrated in Central and South America.
Read more on BNS →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
